Summary
This prediction ended on 30.06.16 with a price of €88.54. The BUY prediction by ler finished with a performance of 3.07%. ler has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -5.233% | -5.233% | -50.298% | -45.190% |
iShares Core DAX® | 0.393% | -2.618% | 11.310% | 10.727% |
iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% | 33.228% |
iShares Nikkei 225® | 1.038% | -8.365% | 7.878% | 1.931% |
iShares S&P 500 | -0.046% | -4.991% | 21.704% | 34.810% |
Comments by ler for this prediction
In the thread Bayer AG diskutieren
Kaufgelegenheit
Es gibt 2 Szenarien:
1. Die Übernahme von Monsanto klappt und das gemeinsame Geschäftsmodell funktioniert oder
2. Die Übernahme scheitert
In beiden Fällen sollte der Bayer-Kurs steigen.
Die 3. Möglichkeit einer Übernahme mit einem Scheitern des gemeinsamen Wegs sehe ich als wenig wahrscheinlich.